Pediatric Cancer

MicroRNA Blood Test for Monitoring Precursor B-ALL Patients

Develop a minimal invasive blood test to increase frequency and long term monitoring of relapse in ALL patients to enable optimal treatment outcome. The blood test is based on 3 microRNA that predict relapse in bone marrow samples taken at diagnosis.

Voting

0 votes
Ideate
Idea No. 201

Attachments

- [ Show all ]